![Sung-Koo Lee](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Fortuna: 14 M $ al 31/07/2026
Sung-Koo Lee currently works at Anterogen Co., Ltd., as Co-Chief Executive Officer & Director.
Mr. Lee also formerly worked at Bukwang Pharmaceutical Co., Ltd., as President, Chief Executive Officer & Director from 2011 to 2013.
Mr. Lee received his undergraduate degree and graduate degree from Seoul National University.
| Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
|---|---|---|---|---|
ANTEROGEN CO., LTD. 12,16 % | 10/07/2026 | 1.217.168 ( 12,16 % ) | 14 M $ | 31/07/2026 |
| Empresas | Cargo | Inicio |
|---|---|---|
| ANTEROGEN.CO.,LTD. | Director Ejecutivo | 16/03/2000 |
| Empresas | Cargo | Fin |
|---|---|---|
| BUKWANG PHARMACEUTICAL CO., LTD. | Director Ejecutivo | 15/03/2013 |
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
| Empresas privadas | 3 |
|---|---|
Bukwang Pharmaceutical Co., Ltd.
 Bukwang Pharmaceutical Co., Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and distributes pharmaceutical products | Health Technology |
Seoul National University
 Seoul National University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Anterogen Co., Ltd.
 Anterogen Co., Ltd. BiotechnologyHealth Technology Develops and wholesales stem cell therapy medicine products | Health Technology |
Selecciona tu edición
Toda la información financiera adaptada al ámbito nacional.
